Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,443
Closed -$225K 235
2024
Q3
$225K Sell
1,443
-146
-9% -$21.7K 0.04% 186
2024
Q2
$235K Sell
1,589
-174
-10% -$27.4K 0.04% 169
2024
Q1
$313K Buy
1,763
+12
+0.7% +$1.83K 0.06% 144
2023
Q4
$249K Buy
+1,751
New +$214K 0.05% 152
2023
Q3
Sell
-1,794
Closed -$237K 181
2023
Q2
$237K Sell
1,794
-94
-5% -$13.9K 0.05% 145
2023
Q1
$313K Sell
1,888
-288
-13% -$47.4K 0.07% 124
2022
Q4
$324K Buy
2,176
+592
+37% +$92.9K 0.07% 126
2022
Q3
$235K Sell
1,584
-34
-2% -$5.44K 0.06% 119
2022
Q2
$242K Buy
1,618
+126
+8% +$24.2K 0.06% 120
2022
Q1
$317K Sell
1,492
-2,571
-63% -$556K 0.07% 118
2021
Q4
$940K Buy
4,063
+731
+22% +$178K 0.19% 57
2021
Q3
$762K Buy
+3,332
New +$835K 0.18% 65

Other funds holding TGT

CFO4Life Group's TGT Position: Q4 2024 in Review

CFO4Life Group sold out of Target (TGT) in Q4 2024, closing a stake of 1,443 shares — an estimated $225K sold.

CFO4Life Group first reported a position in TGT in Q3 2021 and held it in 12 quarters. The position peaked at $940K in Q4 2021. 1,983 funds tracked by Wall St. Rank hold TGT as of Q4 2024.

  • CFO4Life Group reported no remaining Target position as of Q4 2024 after selling out during the quarter.
  • CFO4Life Group sold 1,443 Target shares in Q4 2024, an estimated $225K.
  • CFO4Life Group first reported a position in Target in Q3 2021 and held it in 12 quarters.
  • CFO4Life Group's Target position peaked at $940K in Q4 2021.
  • 1,983 funds tracked by Wall St. Rank held Target as of Q4 2024.

Based on CFO4Life Group's 13F filing for Q4 2024, filed 10 Feb 2025.